OpenAlex 2.086 eser 16 yazar konusu
Çalışmalar
2.086 eser
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 100.0%
Over the past 2 decades, nonalcoholic fatty liver disease (NAFLD) has grown from a relatively unknown disease to the most common cause of chronic liver disease in the world. In fact, 25% of the world's population is currently thought to have NAFLD. Nonalcoholic steatohepatitis (NASH) is the subtype of NAFLD that can p…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 100.0%
Özet henüz yok.
-
OpenAlex üst %1
OpenAlex 100.0%
Özet henüz yok.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %10
OpenAlex 98.5%
Evaluation of needle biopsies and extensive clinicopathological correlation play an important role in the determination of liver allograft dysfunction occurring more than 1 year after transplantation. Interpretation of these biopsies can be quite difficult because of the high incidence of recurrent diseases that show…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.9%
BACKGROUND: Primary biliary cholangitis is a rare, chronic cholestatic liver disease characterized by the destruction of interlobular bile ducts, leading to cholestasis and liver fibrosis. Whether elafibranor, an oral, dual peroxisome proliferator-activated receptor (PPAR) α and δ agonist, may have benefit as a treatm…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 100.0%
BACKGROUND: Effective treatments for patients with primary biliary cholangitis are limited. Seladelpar, a peroxisome proliferator-activated receptor delta agonist, has potential benefits. METHODS: In this phase 3, 12-month, double-blind, placebo-controlled trial, we randomly assigned (in a 2:1 ratio) patients who had…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.8%
BACKGROUND AND AIMS: Electronic health record (EHR)-based research allows the capture of large amounts of data, which is necessary in NAFLD, where the risk of clinical liver outcomes is generally low. The lack of consensus on which International Classification of Diseases (ICD) codes should be used as exposures and ou…
-
Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis # 2009OpenAlex üst %10 OpenAlex 98.8%
UNLABELLED: Nonalcoholic fatty liver disease (NAFLD) is a potentially progressive liver disease that culminates in cirrhosis. Cirrhosis occurs more often in individuals with nonalcoholic steatohepatitis (NASH) than in those with steatosis (nonalcoholic fatty liver [NAFL]). The difference between NAFL and NASH is the e…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.6%
UNLABELLED: Peginterferon alfa-2a results in a sustained response (SR) in a minority of patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB). This study investigated the role of early on-treatment serum hepatitis B surface antigen (HBsAg) levels in the prediction of SR in HBeAg-negative patie…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.6%
UNLABELLED: Peginterferon alfa-2a results in a sustained response (SR) in a minority of patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB). This study investigated the role of early on-treatment serum hepatitis B surface antigen (HBsAg) levels in the prediction of SR in HBeAg-negative patie…
-
YÖKSİS
JCR Q3
OpenAlex üst %10
OpenAlex 97.3%
BACKGROUND/AIMS: Nonalcoholic steatohepatitis (NASH) is a serious disorder with the potential to gradually progress to cirrhosis. It is generally associated with obesity, diabetes and hyperlipidemia. Currently, there is no established therapy for NASH. The aim of the present study was to evaluate the effectiveness of…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex üst %1
OpenAlex 99.4%
BACKGROUND: Progressive familial intrahepatic cholestasis (PFIC) is a group of inherited paediatric liver diseases resulting from mutations in genes that impact bile secretion. We aimed to evaluate the effects of odevixibat, an ileal bile acid transporter inhibitor, versus placebo in children with PFIC. METHODS: Patie…
Akademisyenler
16 akademisyen
- SAVAŞ CUMALİ EFE 104 yazar konusu
- ÇİĞDEM ARIKAN 27 yazar konusu
- FATMA EBRU AKIN 19 yazar konusu
- BUKET DALGIÇ 18 yazar konusu
- NACİYE ŞEMNUR BÜYÜKAŞIK 14 yazar konusu
- DİLARA TURAN GÖKÇE 13 yazar konusu
- KADRİ ATAY 7 yazar konusu
- HASAN ERUZUN 6 yazar konusu
- RAIM ILIAZ 5 yazar konusu
- MÜGE USTAOĞLU DEDE 4 yazar konusu
- ELVAN IŞIK 3 yazar konusu
- HACER FULYA GÜLERMAN 3 yazar konusu